Study vision preservation, cure and outcomes in patients with retinoblatoma in Central America: improving overall survival from 60% to 70%. Study vincristine and carboplatin in low stage local retinoblastoma, saving vision. Study chemotherapy before enucleation in patients with buphthalmous.
